Insitro
Manufacturing · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
279 E Grand Ave, South San Francisco, Ca...Phone Number
(650) 730-7074Website
www.insitro.comRevenue
$7.5 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
5
1
1
1
2
About Insitro
insitro is a drug company focused on accelerating the development of transformative medicines by leveraging machine learning and large-scale data analysis. They aim to decode biology's complexities to provide better drugs more quickly to patients in need. With a diverse team comprising life scientists, data scientists, and engineers, insitro integrates in vitro cellular data with human clinical data to redefine disease and identify key therapeutic insights. Their pipeline includes therapeutic programs across various fields such as metabolism, oncology, and neuroscience.Explore more
Insitro Org Chart
Get the full picture
Sign in to uncover key details.
NA
Manager, Recruiting Operations
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Insitro your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Insitro launches new products
Click to see if Insitro had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Insitro has new funding data
Congratulate Masked Content for being promoted to Masked Content at Insitro
Earning: See what the market has to say on Insitro recently announced quarterly report
Check out if Insitro is spiking on competitors!
Check if Insitro has recently received funding, and reach out quickly before it becomes old news!
Insitro, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Insitro as Masked Content
Find more new buyers
Compare Similar Companies to Insitro
Compare insights from companies similar to Insitro, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Insitro is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Insitro is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Insitro.
Insitro financials insights
Gather financial insights about Insitro, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$100M
2020
Series B
$143M
2021
Series C
$400M
Insitro Tech Stack
A closer look at the technologies used by Insitro
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Person-Based
Search, Medical Research, Artificial Intelligence
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Person-Based
Person-Based
Insitro News & Media
insitro Receives $25 Million in Milestone Payments from Bristol Myers Squibb for ... - Business Wire
insitro, a machine learning-enabled drug discovery and development company, today announced it has received $25 million from Bristol Myers Squibb (NYSinsitro Receives $25 Million in Milestone Payments from Bristol Myers Squibb for the Achievement of Discovery Milestones and the Selection of First Novel Genetic Target for ALS
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--insitro, a machine learning-enabled drug discovery and development company, today announced it has received $25 million from Bristol Myers Squibb (NYSE: BMY) representing both the achievement of discovery milestones and the selection of the first novel target for amyotrophic lateral sclerosis (ALS) that was identified and validated by insitro. The companies signed a collaboration agreement in 2020 to discover new therapies for this disease that lackBetter drugs through AI? Insitro CEO on what machine learning can teach Big Pharma
Artificial intelligence is changing the way industries do business.insitro and Lilly Enter Strategic Agreements to Advance Novel Treatments for Metabolic Diseases
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--insitro and Lilly Enter Strategic Agreements to Advance Novel Treatments for Metabolic Diseases
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Insitro
Sign Up For FreeTo access detailed company insights
insitro is a drug company focused on accelerating the development of transformative medicines by leveraging machine learning and large-scale data analysis. They aim to decode biology's complexities to provide better drugs more quickly to patients in need. With a diverse team comprising life scientists, data scientists, and engineers, insitro integr... Read More
